High quality, price stability commitment to customers
High quality, price stability commitment to customers
PT Meiji Indonesia is a pioneer of quality antibiotic products
for both domestic and international markets. This is the unique
and clear image of PT Meiji Indonesia, a company highly
specialized in pharmaceuticals.
For the past 24 years, it has produced over 215 million vials,
500 million capsules and 500 million tablets, under such medicine
trade marks as Troches, Viccillin, Dibekacin, Kanamycin and
Meixam; all have been used by producers throughout Indonesia, the
ASEAN region and Japan.
All products are guaranteed high quality, with integrated
supervision supported by Meiji Seika Kaisha Ltd Japan standards
and certified by the Indonesian government to local medical
production standards. Products consist of 99 percent prescription
drugs and 1 percent over-the-counter medicines for the domestic
market.
The company and its employees share a perception concerning
the relationship between production quality and employees
welfare: "Employee enhancement brings company enhancement, and
company enhancement translates into improved employee benefits."
PT Meiji Indonesia has won 16 awards at regional as well as
national levels, including one for environmental consciousness
and a subregional first prize for the implementation of norm K3
Chemical industry sector.
PT Meiji Indonesia's President Director, T. Nakazono, pays
major attention to pricing. He is committed to keeping prices
affordable for the public despite the fact that real market
prices have increased from April by 45 percent to 75 percent. It
is untrue, he said, that because of the economic crisis medicine
prices have increased 200 percent. If this has happened, he said,
it is because of a distribution factor or too many speculators.
Nakazono suggested making a pharmaceutical association which
could control price stability. And the government should carry
out tight supervision in order to eliminate speculators and to
stabilize the distribution process and prices of raw materials.